Skip to main content
Clinical Trials/NCT04898855
NCT04898855
Completed
Not Applicable

Programa Online de intervenção Cognitivo-Comportamental Para o Tratamento da Insónia em Sobreviventes Oncológicos

University of Coimbra1 site in 1 country154 target enrollmentAugust 19, 2023

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Insomnia
Sponsor
University of Coimbra
Enrollment
154
Locations
1
Primary Endpoint
Insomnia severity
Status
Completed
Last Updated
last year

Overview

Brief Summary

The main purpose of this study is to determine the treatment effects, feasibility, and acceptability of an internet-based cognitive-behavioral therapy intervention to improve the sleep of Portuguese cancer survivors with insomnia.

Registry
clinicaltrials.gov
Start Date
August 19, 2023
End Date
July 31, 2024
Last Updated
last year
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Responsible Party
Principal Investigator
Principal Investigator

Maria Inês Clara

PhD fellowship at Center for Research in Neuropsychology and Cognitive and Behavioral Intervention

University of Coimbra

Eligibility Criteria

Inclusion Criteria

  • Age 18+ years
  • Provided informed consent
  • Ability to read and write in Portuguese
  • Ability to use a computer and/or smartphone, and the internet
  • History of cancer
  • Have completed primary cancer treatment (survivors who are on hormone and/or other long-term maintenance therapy agencies are eligible to participate)
  • Subclinical or significant symptoms of insomnia (ISI scores\>8)
  • Ongoing sleep medication accepted if the dosage has been stable during the last 3 months
  • No participation in any other interventional study or clinical trial

Exclusion Criteria

  • Age ≤ 18 years
  • Absence of clinically or subclinical significant symptoms
  • No history of cancer
  • Inability to provide informed consent
  • Inability to use a computer and/or smartphone
  • No access to the internet
  • Another untreated sleep diagnosis
  • Current major psychiatric or medical condition
  • Pregnancy or breastfeeding
  • Parallel ongoing psychological treatment for insomnia

Outcomes

Primary Outcomes

Insomnia severity

Time Frame: Changes from baseline to post-intervention (8 weeks after randomization)

Insomnia Severity Index: validated questionnaire among cancer survivors; a 7-item scale with total scores between 0 and 28 where higher scores indicate greater severity

Secondary Outcomes

  • Anxiety(Changes from baseline to post-intervention (8 weeks after randomization))
  • Depression(Changes from baseline to post-intervention (8 weeks after randomization))
  • Health-related quality of life(Changes from baseline to post-intervention (8 weeks after randomization))
  • Cancer-related fatigue(Changes from baseline to post-intervention (8 weeks after randomization))
  • Sleep efficiency(Changes from baseline to post-intervention (8 weeks after randomization))
  • Total sleep time(Changes from baseline to post-intervention (8 weeks after randomization))
  • Sleep onset latency(Changes from baseline to post-intervention (8 weeks after randomization))
  • Number of nocturnal awakenings(Changes from baseline to post-intervention (8 weeks after randomization))
  • Wake after sleep onset(Changes from baseline to post-intervention (8 weeks after randomization))

Study Sites (1)

Loading locations...

Similar Trials